Suppr超能文献

疫苗接种状况对住院COVID-19患者CORADS及计算机断层扫描严重程度评分的影响:一项回顾性研究。

Effect of vaccination status on CORADS and computed tomography severity score in hospitalized COVID-19 patients: A retrospective study.

作者信息

Binay Umut Devrim, Karavaş Erdal, Karakeçili Faruk, Barkay Orçun, Aydin Sonay, Şenbil Düzgün Can

机构信息

Department of Infectious Diseases and Clinical Microbiology, Erzincan Binali Yildirim University, Faculty of Medicine, Erzincan 24000, Turkey.

Department of Radiology, Bandırma 17 Eylül University, Faculty of Medicine, Balıkesir 10200, Turkey.

出版信息

World J Methodol. 2023 Dec 20;13(5):456-465. doi: 10.5662/wjm.v13.i5.456.

Abstract

BACKGROUND

The coronavirus disease 2019 (COVID-19) pandemic is continuing. The disease most commonly affects the lungs. Since the beginning of the pandemic thorax computed tomography (CT) has been an indispensable imaging method for diagnosis and follow-up. The disease is tried to be controlled with vaccines. Vaccination reduces the possibility of a severe course of the disease.

AIM

The aim of this study is to investigate whether the vaccination status of patients hospitalized due to COVID-19 has an effect on the CT severity score (CT-SS) and CORADS score obtained during hospitalization.

METHODS

The files of patients hospitalized between April 1, 2021 and April 1, 2022 due to COVID-19 were retrospectively reviewed. A total of 224 patients who were older than 18 years of age, whose vaccination status was accessible, whose severe acute respiratory syndrome coronavirus 2 polymerase chain reaction result was positive, and who had a Thorax CT scan during hospitalization were included in the study.

RESULTS

Among the patients included in the study, 52.2% were female and the mean age was 61.85 years. The patients applied to the hospital on the average 7 day of their complaints. While 63 patients were unvaccinated (Group 1), 20 were vaccinated with a single dose of CoronaVac (Group 2), 24 with a single dose of BioNTech (Group 3), 38 with 2 doses of CoronaVac (Group 4), 40 with 2 doses of BioNTech (Group 5), and 39 with 3 doses of vaccine (2 doses of CoronaVac followed by a single dose of BioNTech, Group 6). CT-SS ranged from 5 to 23, with a mean of 12.17.CT-SS mean of the groups were determined as 14.17, 13.35, 11.58, 10.87, 11.28, 10.85, respectively. Accordingly, as a result of the comparisons between the groups, the CT-SS levels of the unvaccinated patients found to be significantly higher than the other groups. As the vaccination rates increased, the rate of typical COVID-19 findings on CT was found to be significantly lower.

CONCLUSION

Increased vaccination rates in COVID-19 patients reduce the probability of typical COVID-19 symptoms in the lungs. It also reduces the risk of severe disease and decreases CT Severity Scores. This may lead to a loss of importance of Thorax CT in the diagnosis of COVID-19 pneumonia as the end of the pandemic approaches.

摘要

背景

2019年冠状病毒病(COVID-19)大流行仍在持续。该疾病最常影响肺部。自大流行开始以来,胸部计算机断层扫描(CT)一直是诊断和随访不可或缺的成像方法。人们试图通过疫苗来控制该疾病。接种疫苗可降低疾病严重病程的可能性。

目的

本研究的目的是调查因COVID-19住院患者的疫苗接种状况是否会对住院期间获得的CT严重程度评分(CT-SS)和CORADS评分产生影响。

方法

回顾性分析2021年4月1日至2022年4月1日期间因COVID-19住院患者的病历。共有224名年龄大于18岁、疫苗接种状况可查、严重急性呼吸综合征冠状病毒2聚合酶链反应结果为阳性且住院期间进行了胸部CT扫描的患者纳入本研究。

结果

纳入本研究的患者中,52.2%为女性,平均年龄为61.85岁。患者平均在出现症状后7天入院。其中63名患者未接种疫苗(第1组),20名接种了单剂科兴疫苗(第2组),24名接种了单剂辉瑞疫苗(第3组),38名接种了2剂科兴疫苗(第4组),40名接种了2剂辉瑞疫苗(第5组),39名接种了3剂疫苗(2剂科兴疫苗后接种1剂辉瑞疫苗,第6组)。CT-SS范围为5至23,平均为12.17。各组的CT-SS平均值分别确定为14.17、13.35、11.58、10.87、11.28、10.85。因此,通过组间比较发现,未接种疫苗患者的CT-SS水平显著高于其他组。随着疫苗接种率的提高,CT上典型COVID-19表现的发生率显著降低。

结论

COVID-19患者疫苗接种率的提高降低了肺部出现典型COVID-19症状的概率。它还降低了重症疾病的风险并降低了CT严重程度评分。随着大流行接近尾声,这可能导致胸部CT在COVID-19肺炎诊断中的重要性降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8312/10789104/86ce2cf68cb8/WJM-13-456-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验